CME Group & Ondo Global Markets

CME Group: Likely to post marginal decline in revenue and profit. Stock down year-to-date amid regulatory worries.

Ondo Global Markets: Expected to report higher revenue and profit, stock up about 11% year-to-date.

CME Group: CME Group is initiating a lawsuit against the United States — United States Commodity Futures Trading Commission over the approval of perpetual futures, viewing it as a competitive threat and a regulatory overstep. Its shares fell after the CFTC's approval, reflecting investor concern.

Ondo Global Markets: Ondo Global Markets, another major exchange operator, saw its shares drop following the United States — United States Commodity Futures Trading Commission's approval of perpetual futures, indicating broader market concern among traditional exchanges about increased competition.

CME Group: CME reported strong profit, but its stock is under pressure from the threat of perpetual futures competition.

Ondo Global Markets: Cboe reported a surge in Q2 profit and record options volumes, with shares up over 18% this year. The company benefits from elevated volatility and its exclusive S&P 500 options license.

CME Group: Competitor that rolled out 24x7 trading of crypto futures and options in late May.

Ondo Global Markets: Competitor planning to launch 23x5 trading of U.S. equities on its EDGX exchange.

CME Group: CME Group also beat Q2 profit estimates, but its shares have declined more than Nasdaq's this year.

Ondo Global Markets: Ondo Global Markets is set to report Q2 results next week.